gender transition procedures; informed consent

SB 1099 requires health professionals to obtain written informed consent before prescribing or performing gender transition procedures, such as puberty-suppressing medications, cross-sex hormones, or surgeries. It mandates disclosure of specific risks - including uncertain long-term effects, potential infertility, bone density issues, surgical complications, and alternatives like therapy - before any procedure. Consent forms must be documented per state guidelines and retained for 15 years. The bill directly affects transgender patients seeking medical transition care and the healthcare providers who administer it, with civil liability for failing to meet these disclosure requirements.